28.10.2025 Notice of Consolidation

27.06.2025 Notice of Consolidation

Notice of Delisting - 13.10.2025

I nostri ETP

White Label

Società

Trading Hub

Income
Come investire
  • Leverage & Inverse ETPs
Tutti i prodotti
  • Commodities
All Commodities ETPs
  • Income ETPs
Tesla Options ETP
NVIDIA Options ETP
Gold+ Yield ETP
To IncomeShares

All ETPs

Discover 150+ Products

All ETPs
  • Market Insights
See All Insights
  • Formazione Scolastica
See All Education
  • Instruments

ETP Guide

Learn about our Long & Short ETPs

Download Guide
  • White Label
About White Label

Become Our Client

Bring your investment idea to life

Contact us
  • Su di noi
  • Perché sceglierci
  • FAQs

Newsletter

Get your weekly updates

Subscribe
ISIN: - COPYS

-

iNAV as of -T
Variazione da inizio anno
ISIN: - COPY

Più fattori di leva:

–

10 Days to Earnings

Più fattori di leva

–

Più fattori di leva

– – – – –

Come investire

Perché L’ETP 3x Long Exxon?

Aumenta l’esposizione senza la necessità di un conto di margine come i CFD.

Negoziato tramite il tuo broker locale e nella tua valuta.

Garantito fisicamente.

Semplice. Negoziato come qualsiasi altro titolo.

Related Short & Leveraged ETPs

-

$-

-

-

-

$-

-

-

-

$-

-

-

-

$-

-

-

-

$-

-

-

-

$-

-

-

Rendimento

Dati al

–

JPML2
2JPM
JP2E
%
1M
3M
1Y
ALL
1M
3M
1Y
ALL

Summary

1D

-

1M

-

3M

-

YTD Return

-

1Y

-

ALL (Annualized)

-

ALL (Cumulative)

-

Volatility

Annualized Vol

-

52 Week

52 Week High

-

52 Week Low

-

Average Turnover

Daily Volume

-

3M

-

Valori degli asset sottostanti

-

–

–

AUM

-

–

XOM3

Passività

-

Documenti ETP

Notices

Related Articles

  • MARKET INSIGHTS

UnitedHealth Q3 Earnings Beat but Margins Squeezed

Despite stronger Q3 results and higher guidance, UnitedHealth faces profit margin strain.
Read more
Article Icon_ Q3 FY 2025 earnings UNH

UnitedHealth Q3 Earnings Beat but Margins Squeezed

Despite stronger Q3 results and higher guidance, UnitedHealth faces profit margin strain.
  • MARKET INSIGHTS
Read
Article Icon_ Q3 FY 2025 earnings UNH

UnitedHealth Q3 Earnings Beat but Margins Squeezed

Despite stronger Q3 results and higher guidance, UnitedHealth faces profit margin strain.
Read

Welcome to Leverage Shares

INVESTOR TYPE:

LOCATION:

Please confirm the Terms and Conditions by clicking on “I agree”.

This website is for informational purposes only.

This website is accessible to retail investors in the EU for informational purposes only. Leverage Shares does not directly distribute to retail investors. Retail clients should not rely on any of the information provided and should seek independent financial advice.

Information contained in this website is intended only to provide general and preliminary information and does not constitute any legal or investment advice, an offer to sell or solicitation to buy any security, including shares of any Exchange Traded Products (“ETPs”).

An investment in the promoted ETPs may only be made based on the ETPs´ legal documentation and will be subject to terms and conditions contained therein.

The information provided on this site is not directed to any United States person or any person in the United States, any state thereof, or any of its territories or possessions. The ETPs shown on this website are not available for sale in the U.S. or to a U.S. person.

I acknowledge having my legal residence in the selected location.

Leverage Shares does not directly distribute to retail investors.

Please contact your financial adviser, or other investment professional, if you would like to discuss whether these products may be suitable for you.

This website is intended for U.S. residents.

The content on this website is for informational purposes only and is educational in nature.

The material contained on this website is not intended as a recommendation to buy, sell or hold any security or to adopt any investment strategy.

Please confirm the Terms and Conditions by clicking on “I agree”.

This website is for informational purposes only.

Information contained in this website is intended only to provide general and preliminary information to EU regulated firms such as Investment Intermediaries and Asset Managers. This information does not constitute an offer to sell or solicitation to buy any security, including shares of any Exchange Traded Products (“ETPs”).

An investment in the promoted ETPs may only be made based on the ETPs´ legal documentation and will be subject to terms and conditions contained therein.

The information provided on this site is not directed to any United States person or any person in the United States, any state thereof, or any of its territories or possessions. The ETPs shown on this website are not available for sale in the U.S. or to a U.S. person.

I acknowledge having my legal residence in the selected location.

Please confirm you have read and accept the Terms and Conditions by clicking on
“I agree”.

This website is for informational purposes only.

Information contained in this website is directed only at institutional investors and investment professionals intended only to provide general and preliminary information to such as FCA regulated firms such as Independent Financial Advisors (IFAs) and Wealth Managers. Nothing on this website is intended to information does not constitute an offer to sell or solicitation to buy any security, including shares of any Exchange Traded Products (“ETPs”).

An investment in the promoted ETPs may only be made based on the ETPs legal documentation and will be subject to terms and conditions contained therein.

The information provided on this site is not directed to any United States person or any person in the United States, any state thereof, or any of its territories or possessions. The ETPs shown on this website are not available for sale in the U.S. or to a U.S. person.

I confirm I am a professional investor and acknowledge having my legal residence in the selected location.

This website is intended for U.S. residents.

The content on this website is for informational purposes only and is educational in nature.

The material contained on this website is not intended as a recommendation to buy, sell or hold any security or to adopt any investment strategy.

x

Ricevi la Newsletter

Rimani sempre aggiornato sugli ultimi avvenimenti. Accedi a contenuti premium e goditi in prima fila gli approfondimenti esclusivi tramite la nostra newsletter.

x

Ricevi la Newsletter

Rimani sempre aggiornato sugli ultimi avvenimenti. Accedi a contenuti premium e goditi in prima fila gli approfondimenti esclusivi tramite la nostra newsletter.